Showing results (1901-1910 of 2,433) with videos related to

Sort By:
Pageof 244
Arteriosclerosis, Thrombosis, and Vascular Biology|February 8, 2014
Tissue-specific RNA-Seq in human evoked inflammation identifies blood and adipose LincRNA signatures of cardiometabolic diseasesYichuan Liu, Jane F Ferguson, Chenyi Xue, et al.
European Journal of Preventive Cardiology|October 31, 2012
Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the ARIC studyChiadi E Ndumele, Kunihiro Matsushita, Brad Astor, et al.
Journal of Lipid Research|September 8, 2012
Adiponectin and the mediation of HDL-cholesterol change with improved lifestyle: the Look AHEAD StudyL Maria Belalcazar, Wei Lang, Steven M Haffner, et al.
American Journal of Preventive Cardiology|April 26, 2024
Statin utilization and cardiovascular outcomes in a real-world primary prevention cohort of older adultsAaron J Walker, Jianhui Zhu, Floyd Thoma, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 27, 2022
APOL1 Kidney Risk Variants and ProteomicsTeresa K Chen, Aditya L Surapaneni, Dan E Arking, et al.
Journal of the American Heart Association|August 25, 2021
Racial Disparities in Modifiable Risk Factors and Statin Usage in Black Patients With Familial HypercholesterolemiaAnandita Agarwala, Nathan Bekele, Elena Deych, et al.
Obesity Surgery|April 4, 2008
Bariatric surgery: low mortality at a high-volume centerGarth H Ballantyne, Scott Belsley, Daniel Stephens, et al.
International Journal of Cardiology|July 13, 2013
Patients with severe chronic kidney disease benefit from early revascularization after acute coronary syndromeHenry D Huang, Mahboob Alam, Ihab Hamzeh, et al.
The Journal of Clinical Endocrinology and Metabolism|August 10, 2020
Sex Hormones and Incident Heart Failure in Men and Postmenopausal Women: The Atherosclerosis Risk in Communities StudyDi Zhao, Eliseo Guallar, Christie M Ballantyne, et al.
European Heart Journal Open|November 30, 2023
Effectiveness of icosapent ethyl on first and total cardiovascular events in patients with metabolic syndrome, but without diabetes: REDUCE-IT MetSynMichael Miller, Deepak L Bhatt, Eliot A Brinton, et al.
Pageof 244